Eroxon® works through a unique physical action. The “physical” rather than “pharmacological” effect means it is classified as a medical device. Eroxon® is approved as a medical device in the European Union under the EU Regulation on Medical Devices (“the MDR”) for the treatment of erectile dysfunction. This pan-European legislation governs the manufacture and supply of medical devices, and lays out stringent legal requirements for device performance, safety, and quality. Eroxon® is also approved in the UK under the new UKCA procedure.
The information on this site is intended for consumers and healthcare professionals in the European Economic Area or the United Kingdom. Eroxon is not available in jurisdictions outside the European Economic Area or the United Kingdom. Users outside these jurisdictions,
please click here.